Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

Click for more information

0.00%

0.8¢ anagenics limited

Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received, page-173

First 173 Last

Share
Profile

Follow
Ooogerbooger

1,612 Posts.

409

15/04/20

23:11

Post #: 44065831
Share

Originally posted by EML333: ↑

ok. Let me clarify few key concepts of antibody testing for vaccines.
its checked routinely to check efficacy of vaccines like hepatitis vaccine, varicella etc

and its a blood test done in authorised labs to check quantitative titre of antibody to asses immunity response to vaccine. Quantitative because if antibodies start to fall after a certain level then it shows the host is no longer immune- and sometimes needs repeat booster doses.

the immunity/ antibodies after for example influenza flu shot starts to fall and fall by 50% after 6 months and last 10-12 months and that’s why you need a vaccine every year.

and how we measure it is by measuring the titre aka quantity of antibodies by sophisticated blood analysis in lab.

So, a point of care positive/ negative test with low sensitivity has absolutely NO USE in these analysis.

POCT HAVE NO USE IN VACCINE TRIALS.
full stop !

Expand

Apart from the bit about influenza, this post is largely true.

CDY Price at posting: 23.0¢ Sentiment: Sell Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CNB

Carnaby Resources hits copper at Mohawk, QLD

YAL

Yancoal makes it into the ASX200 in latest S&P rebalance

CBL

Control Bionics expands into UK and Irish markets with NeuroNode device

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

GDC

Global Data Centres not clear on future operations after AirTrunk sale payout

There are more pages in this discussion • 222 more messages in this thread...

First 173 Last

Add AN1 (ASX) to my watchlist